CClinicalTrials.gg
CompletedNCT02266693Updated Feb 15, 2019

Transdiagnostic iCBT for Depression and Anxiety

An interventional study of iCBT in Major Depressive Disorder, Social Anxiety Disorder and Panic Disorder, sponsored by Centre for Addiction and Mental Health. Completed at 1 site in Canada. Open to participants aged 18 Years to 29 Years. Per ClinicalTrials.gov, last updated 2019-02-15.

Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years to 29 Years
Sex
All
01

Study summary

This 8-week, pilot randomized, controlled trial to evaluate the benefits of transdiagnostic Internet-based CBT (iCBT) in young adults with MDD, SAD, PD or GAD. The investigators hypothesize that patients who receive iCBT will show significant improvement in anxiety symptoms and functioning, compared to a wait-list group. This pilot randomized controlled study will assess the efficacy of transdiagnostic iCBT in 60 young adults.

Read the detailed description

Unipolar depression and anxiety disorders (particularly social anxiety disorder [SAD], generalized anxiety disorder [GAD] and panic disorder [PD]) are among the most common forms of mental illnesses. They often have a chronic course, and are frequently associated with co-morbidities, significant disability, and poor quality of life. Published epidemiologic studies indicate that these conditions typically emerge during early adolescence and adulthood, and are often poorly recognized, resulting in delay of several years before help is sought. Such delay is often attributed to the non-recognition of the significance of the symptoms, lack of information on or access to services, and embarrassment and fear of stigma, but each effective early treatment can reduce co-morbidities and improve prognosis.

Cognitive behaviour therapy (CBT) is recognized as the single most effective psychological intervention for depression and anxiety, but accessibility is affected by therapist costs and long wait times for OHIP-covered services. Internet-based CBT (iCBT) is an innovative alternative with higher accessibility and cost-efficiency than group CBT, but with comparable efficacy. Transdiagnostic models of iCBT that treat depression, SAD, PD and GAD within one program have shown efficacy in preliminary trials and may offer even greater accessibility and economy, as several depressed and anxious populations can be treated with the same protocol. As a non-pharmacological treatment option enhanced by technological advances, iCBT is likely to appeal to tech-savvy young adults. However, it has not been evaluated specifically in a young adult population, thus far.

This 8-week, multi-site, randomized, controlled trial to evaluate the benefits of trandiagnostic iCBT in 60 young adults with unipolar depression and/or SAD, PD or GAD. We hypothesize that patients who receive iCBT will show significant improvement in depressive and anxiety symptoms and functioning, compared to a wait-list group.

02

Conditions studied

  • Major Depressive Disorder
  • Social Anxiety Disorder
  • Panic Disorder
  • Generalized Anxiety Disorder

Keywords

  • Cognitive Behavioural Therapy
  • Internet Based
  • CBT
  • Transdiagnostic
  • MDD
  • PD
  • SAD
  • GAD
  • iCBT
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,388 are open to participants now.

This study's enrollment of 77 is close to the median of 80 across 4,170 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Centre for Addiction and Mental Health is the lead sponsor of 327 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age range (18-29 years).
  2. Primary diagnosis of MDD, SAD, PD and/or GAD, per the DSM-IV-TR.
  3. A score ≥17 on the first 17 items of the Hamilton Depression Rating Scale (HAM-D)55
  4. A score ≥17 on the Hamilton Anxiety Rating Scale (HAM-A)56.
  5. Score ≥50 on the Leibowitiz Social Anxiety Scale (LSAS),57 ≥10 on the Panic Disorder Severity Scale (PDSS)58 and/or ≥60 the Penn State Worry Questionnaire (PSWQ).59
  6. Currently unmedicated or on stable and adequate doses of medication for at least 4 weeks.
  7. Co-morbidities are allowed and will be documented.

Exclusion criteria

Exclusion Criteria:

  1. Primary diagnosis of any psychotic disorder or any other anxiety disorder (OCD, PTSD).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    ICBT Group

    The iCBT program consists of weekly online lessons, weekly homework assignments, regular automatic email reminders about lessons and homework, weekly contact via phone or email with a CBT therapist, and access to a large online library of written resources about depression and anxiety and application of CBT skills. The CBT therapist contacts all participants once a week to review lessons, assist patients with treatment difficulties, reinforce progress and encourage continued engagement with the program. Therapist-patient contact is limited to 10 minutes per patient per week.

    Behavioral: iCBT

  • No intervention
    Waitlist Group

    Upon completion of the 8-week study wait-list period (i.e. their study participation), the opportunity to participate in iCBT, outside the study framework will be provided.

Interventions

  • BehavioraliCBT

    The iCBT program consists of weekly online lessons, weekly homework assignments, regular automatic email reminders about lessons and homework, weekly contact via phone or email with a CBT therapist, and access to a large online library of written resources about depression and anxiety and application of CBT skills. The CBT therapist contacts all participants once a week to review lessons, assist patients with treatment difficulties, reinforce progress and encourage continued engagement with the program. Therapist-patient contact is limited to 10 minutes per patient per week.

    Also known as: Internet based Cognitive Behavioural Therapy

06

What researchers measure

Primary outcomes

  1. Change in Hamilton Depression Rating Scale (HAM-D) Total Score

    Time frame: Baseline to study endpoint (Week 8)

  2. Change in Hamilton Anxiety Rating Scale (HAM-A) Total Score

    Time frame: Baseline to study endpoint (Week 8)

  3. Change in Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR) Total Score

    Time frame: Baseline to study endpoint (Week 8)

  4. Change in Liebowitz Social Anxiety Scale (LSAS) Total Score

    Time frame: Baseline to study endpoint (Week 8)

  5. Change in Panic Disorder Severity Scale Total Score

    Time frame: Baseline to study endpoint (Week 8)

  6. Change in Penn State Worry Questionnaire Total Score

    Time frame: Baseline to study endpoint (Week 8)

Secondary outcomes

  1. Change in Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) Total Score

    Time frame: Baseline to study endpoint (Week 8)

  2. Change in Sheehan Disability Scale (SDS) Total Score

    Time frame: Baseline to study endpoint (Week 8)

  3. Change in Clinical Global Impression (CGI)

    Time frame: Baseline to study endpoint (Week 8)

07

Study locations

1 site
  • Centre for Addiction and Mental Health
    Toronto, Ontario M5T 1R8, Canada
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02266693
Lead sponsor
Centre for Addiction and Mental Health
Responsible party
Arun Ravindran (Principal Investigator, Centre for Addiction and Mental Health) — Principal investigator
First posted
Oct 17, 2014
Start date
Aug 2014
Primary completion
Aug 2018
Completion
Aug 2018
Last update
Feb 15, 2019

Study contacts

Arun Ravindran, MD, PhD
principal investigator · Centre for Addiction and Mental Health

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion